Email LinkedIn Twitter

Pharmaceutical Advocacy Groups Focus on Value-of-Care Initiatives

CHAPEL HILL, N.C. – October 7, 2011 – As bio-pharmaceutical companies lose the ability to communicate externally because of increased regulatory and media scrutiny, the role of internal Advocacy groups will become more important to a company’s success. These groups will tackle the emphasis on cost effectiveness of care by communicating concepts and arranging programs and partnerships that address the value of care.

Since internal Advocacy groups are not known for large budget or staff numbers, more than 75 percent of Advocacy groups employ differentiated service levels to different internal customers to ensure that scarce resources are allocated to the points of greatest economic impact or leadership authority, such as value of care initiatives, according to "Advocacy Excellence: Optimizing Group Structure & Operations," primary research conducted by Best Practices, LLC.

Download a complimentary white paper at that includes selected best practices drawn from quantitative and qualitative research with advocacy leaders from 11 leading biopharmaceutical companies.

Key insights include:
  • More than half of the respondents use centralization in Advocacy. More than a third employs a hub-and-spoke structure which tends to set strategy at headquarters and communicate back-and-forth with individual countries to reflect their local needs and requirements.
  • Corporate is the largest single funding source for Advocacy groups, with 56% of participants receiving at least some funds from corporate.

"Advocacy Excellence: Optimizing Group Structure & Operations" is a 60-page report that contains more than 110 benchmark metrics and 20 data graphics, providing executives working in advocacy with valuable insights on geographic and functional factors that drive advocacy group structure as well as advocacy reporting relationships and how groups align themselves with internal customers.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.

Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information